NVision

NVision is a private German quantum-healthcare company developing quantum-enhanced platforms for medical imaging and drug development. Its lead platform, POLARIS, is a quantum-enhanced MRI hyperpolarization system designed to amplify signals from sugar-based imaging agents and enable real-time metabolic imaging on standard MRI scanners, with an initial focus on oncology treatment-response assessment. The company is also expanding into quantum computing through its Photonic Integrated Quantum Circuits (PIQC) platform, which uses organic molecule-based qubits on photonic chips to support drug design and therapy validation. NVision positions these capabilities as an end-to-end "compute and validate" approach for healthcare, combining quantum sensing with quantum computation. The company appears to be commercializing research-use and clinical research imaging systems rather than developing therapeutic drug assets of its own.